1353900-92-1

Basic information

• Product Name: ABT-530
• Synonyms: ABT-530;Glecaprevir/pibrentasvir
• CAS NO: 1353900-92-1
• Molecular Formula: C57H65F5N10O8
• Molecular Weight: 1113.180216
• EINECS: -0
• Mol File: 1353900-92-1.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.363±0.06 g/cm3(Predicted)
• Storage Temp.: -20°C Freezer, Under inert atmosphere
• Solubility: DMSO (Slightly), Methanol (Slightly), Water (Slightly)
• PKA: 9.76±0.10(Predicted)
• CAS DataBase Reference: ABT-530(CAS DataBase Reference)
• NIST Chemistry Reference: ABT-530(1353900-92-1)
• EPA Substance Registry System: ABT-530(1353900-92-1)

Safety Data

• Hazardous Substances Data: 1353900-92-1(Hazardous Substances Data)

Usage

Description

ABT-530 is a pharmaceutical compound with potential applications in various industries due to its unique properties and characteristics. It is known for its ability to interact with biopolymers and macromolecules, making it a promising candidate for different uses.

Uses

Used in Antiviral Applications:
ABT-530 is used as an antiviral agent for the inhibition of hepatitis C virus NS3/4A protease. This application is particularly relevant in the pharmaceutical industry, where the development of effective treatments for viral infections is a priority.
Used in Drug Delivery Systems:
In the field of drug delivery, ABT-530 can be employed to enhance the efficacy and bioavailability of various pharmaceutical compounds. Its ability to interact with biopolymers and macromolecules allows for the development of novel drug delivery systems that can improve the therapeutic outcomes of different medications.
Used in Other Industries:
While the primary applications of ABT-530 are in the pharmaceutical and drug delivery industries, its unique properties may also make it suitable for use in other fields. Further research and development would be required to explore these potential applications and determine the specific benefits of using ABT-530 in these contexts.